Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 791

PDF Downloaded: 1240


Get Permission Maurya, Manisha, Singh, Gupta, Agarwal, Singh, Singh, Shrivastav, and Mehbub Ul Kadir: Ocular disorders associated with obstructive sleep apnea: A review


Introduction

Sleep disorders have become quite common these days. About 1 out of 4 men and 1 out of 10 women have sleep disorder of one type or the other. Sleep apnoea is one such common disorder. Sleep apnea was first time discovered in 1965 while monitoring abnormal breathing pattern during sleep in Pickwickian syndrome.1 It is of 3 types i.e. central, obstructive and mixed. Central sleep apnoea is when the defect is in the respiratory centre causing decreased respiratory drive and hence ventilation. Obstructive sleep apnoea [OSA] involves the repetitive collapse of the pharyngeal airways while sleeping resulting into temporary reduced and shallow breathing i.e. hypopnoea or transient complete cessation i.e. apnoea. Mixed sleep disorder is characterised by events of central and mixed apnea.

According to the various studies prevalence of OSA is between 2-10% of the adult population and it is among the common chronic respiratory diseases.2, 3

Clinically OSA is defined as at least 5 apnoea-hypopnoea events per hour of sleep.4 OSA is graded into 3 categories i.e. mild, moderate and severe according to the apnoea-hypopnoea index [AHI]. Mild OSA is 5-15 events of AHI per hour, moderate OSA is 15-30 per hour and severe will be more than 30 events per hour.5

The treatment of OSA includes behavioural modifications, continous positive airway pressure therapy [CPAP], medicine or surgery. Untreated patients may have long-term clinical consequences including cardiovascular disorders, neurocognitive dysfunction, metabolic dysfunction, respiratory failure and daytime hypersomnolence.6, 7 In OSA, long-term hypoxia of various ocular tissues may induce several ocular disorders. In this review, we would like to highlight the ophthalmological associations of OSA, their pathogenesis and outcomes with the treatment of OSA.

Epidemiology

OSA is more common in men than women. Almost 13% of men and 6 % of women aged 30-70 years suffer from moderate to severe grades of OSA.8 Other researchers reported high prevalence of symptomatic OSA ranging from 22% to 24% in men and 9% to 17% in women.9, 10 It has been reported that 82% of men and 93% women having moderate to severe obstructive sleep apnea remain undiagnosed.11 The serious outcomes of OSA are cardiovascular and neurological disorders like heart attack and stroke. OSA is found in 60%-70% of patients having stroke or ischemic heart disease.12 It was reported that several ophthalmic diseases are associated with OSA: floppy eye syndrome, primary open angle glaucoma, optic neuropathy, keratoconus, papilledema etc.13 Glaucoma is the leading cause of blindness worldwide. Prevalence of OSA in patients of primary open glaucoma is about 2% as in the general populations.14 Mojon DS reported prevalence of glaucoma in OSA approximately 4 times higher than the expected population rate.15 However, Hirunwiwtkul P et al. 2010 reported higher prevalence of POG (20%) with OSA.14

Clinical Course of OSA

Patients of OSA usually present with excessive daytime sleepiness, persisting fatigue, irritability, nocturia, memory loss, morning headaches.16, 17 The symptoms of OSA are missed most often. It is the patient's attendants who complaint of snoring, choking, snorting or the respiratory cessation while sleeping. Early diagnosis of OSA is quite important as if left undiagnosed it might result in decreased quality of life, hampered productivity, increased chances of RTA related injuries and further increasing mortality.18, 19, 20

Risk Factors

OSA is a multifactorial disorder. Risk factors include anatomical as well as non-anatomical. A certain amount of anatomical impairment of upper airways is essential for OSA to occur.21, 22 This is the reason, why most treatment modalities target anatomical abnormalities. Certain lumen shapes of pharynx, increased length and narrow airways at single or multiple sites have been identified in patients of OSA, which can cause pharyngeal collapse while sleeping.23, 24, 25, 26 The structures acting as contributory factors for crowding of airways and further collapse are genioglossus, soft palate, lateral wall of pharynx and epiglottis which all are dilatory muscles.

Among the non-anatomical risk factors, obesity is very important. So, neck circumference is measured on routine basis in the clinics and is being used as a predictor for risk assessment of OSA. Increased obese population has lead to increased prevalence of OSA also. Almost 50-60% patients with obesity and metabolic syndrome also suffer from OSA,27, 28 which might act as a confounding factor in increasing the cardiovascular burden, also seen in patients of metabolic syndrome & diabetes.29 Other risk factors include male gender, alcohol [causing upper respiratory tract muscle depression], short neck, physiological variations or anatomical defects e.g. adenoid hypertrophy, retrognathia, macroglossia, reduced upper respiratory size, [either due to obesity or other pathologies associated with excessive fat deposition in soft tissue of pharynx], cardiovascular risk factors including insulin resistance, lipid dysregulations and essential hypertension.30 Previous studies have demonstrated that OSA is associated with various cardio-vascular events like myocardial infarction, arrhythmias, heart failure & ischemic stroke.31, 32, 33

Metabolic Alterations in OSA

OSA has been found to be associated with several metabolic derangements. Most importantly it has been found to be associated independently with insulin resistance, showing that it may be have an important role in development of diabetes mellitus type 2 and also metabolic syndrome (MS). MS is a group of metabolic derangements predicting risk of developing type II diabetic mellitus and atherosclerotic cardiovascular disease. MS includes obesity, insulin resistance, dyslipidemia and hypertension. Syndrome Z was the term that was given to the association of OSA & MS earlier. It has also been said that OSA by itself is a “metabolic disorder” and is one of the component of MS.34 A case control study has reported that patients of OSA with AHI>15 were associated with increased prevalence of MS.35 An another study demonstrated that OSA patients were six times more at risk to develop MS than those without OSA with BMI, smoking and age adjusted. But this study showed that no independent association is present with insulin resistance and OSA.36 Various cross-sectional studies have suggested link of presence and severity of OSA and presence of glucose intolerance, insulin resistance & diabetes.35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46 There are other studies based on large population, which have shown the association of severity of OSA determined by AHI and the magnitude of glucose intolerance and that of insulin resistance.47, 48, 49, 50, 51, 52 Several studies have stated that OSA has a propensity to increase risk of cardiac disease through above stated cardio-metabolic de-arrangements.53, 31 It has associations with the diseases like ischemic stroke, arrhythmias, and heart failure. So, OSA is an entity that may affect the underlying cardiac disease’s prognosis.

Pathophysiology of OSA

The repetitive episodes of apnoea –hypopnoea seen in OSA cause hypercapnia & hypoxia. This hypoxia in return causes systemic and pulmonary vasoconstriction due to activation of sympathetic nervous system. This repetitive episodic intermittent hypoxia & the re-oxygenation simulates the ischemic-reperfusion theory and may lead to free radical generation, increased levels of homocysteine and cysteine. Various studies have confirmed association of OSA with increased oxidative stress markers.54, 55, 56, 57, 58 Sleep deprivation via neuro-humoral pathways also activate systemic inflammation.59, 60, 61 Inflammation induced vascular endothelial injury [VEC] damages coronary arteries leading to cardiac ischemia.33, 62 There is release of various proteins in VEC injury which act as precursors of cardio-vascular disorders. These can be used as biomarkers of cardio-vascular disease even in patients of OSA without symptoms e.g. protein YKL-40, MMR-9.5, 63 Also hypoxia in the adipose tissues induces lipolysis, mitochondrial damage, decreased adiponectin levels and increased leptin levels which can cause cardio-metabolic dysfunction.

Systemic Disorders Associated with OSA

Common systemic associations with OSA are cardiovascular disorders, stroke & transient ischemic attacks, depression, daytime sleepiness, fatigue, irritability, [they are symptoms of OSA not systemic disorders] insulin resistance and thrombosis etc.11, 64 Hanis M et al reported that 21-41% patients of OSA had depression. The systemic hypertension, pulmonary hypertension, nocturnal cardiac dysrhythmias, ventricular failure and myocardial infarction are common cardiovascular disorders associated with OSA.65, 66 It has been reported that about 40% of diagnosed patients of OSA had systemic hypertension. The apneic episodes of OSA may lead to sympathetic overstimulation, oxidative stress, endothelial damage and platelet activation; all contribute to cardiovascular disorders.67, 68

Ophthalmic Associations

OSA involves various systems of body and eye is not an exception. The most common eye events that have shown association with OSA are floppy eyelid syndrome, glaucoma, non-arteritic anterior ischemic optic neuropathy, central serous retinopathy, retinal vein occlusions, papilloedema, diabetic retinopathy, papillary conjunctivitis, recurrent corneal erosions, keratitis, corneal punctate epitheliopathy, dry eye syndrome and keratoconus. Since OSA usually remains undiagnosed for a long time and some of the ophthalmological associations have irreversible visual outcome too. So, it becomes important for regular ophthalmic consultation, after the patient is diagnosed for OSA. Main underlying mechanisms remain the same i.e. hypoxia and mechanical injuries. Pathogenesis of individual entities has been described below.

Floppy eyelid syndrome

It is a condition where eyelids become everted easily with slight upward traction or spontaneously and become elastic and flaccid. In literature, one study suggested that 96% of the patients who had floppy eyelid syndrome [FES] were also associated with OSA69 and the prevalence of OSA patients with FES varies from 2-25.8%.69, 70

FES is usually seen in middle aged, male gender and overweight subjects. Because of the eversion of the upper eyelid, cornea gets exposed during sleep which contributes to ocular surface disorders e.g. dry eye, corneal ulceration, scarring, exposure keratopathy, neovascularisation and infection which might latter cause corneal perforations as well.71, 72, 73 As the eyelid is everted and the conjunctiva is irritated by being rubbed against the pillow while sleeping continuously, it may further cause chronic papillary conjunctivitis. When eyelids undergo constant mechanical trauma, it might lead to lid oedema, meibomitis, ptosis, dermatochalasis, ectropion and trichiasis. Also repeated trauma to the exposed cornea may also result in keratoconus.72, 73

Histological findings also indicate common mechanisms of FES & OSA. OSA is associated with pharyngeal collapse, which in turn is due to connective tissue compromise against the increased thickness of neck.

Two theories have been proposed for FES development in OSA; mechanical stress & transient tissue ischemia. FES histologically has increase in elastolytic metalloproteinase enzymes, hence leading to decreased elastin fibres of the tissue, which is associated with chronic inflammation of the lid. Also patients of FES experience symptoms often on the side they usually sleep on, correlating with the mechanical stress theory of FES. The events of hypoxia, transient tissue ischemia occurring secondarily in apneic episodes have been found to cause vessel damage and chronic lid inflammation.74

Acar et al. in a study showed low schirmer-I & tear break up time readings and increased corneal staining in patients with OSA and the changes in the values corroborated with the severity of OSA.75 Acar et al. also demonstrated that all the above mentioned impaired findings showed significant improvement in moderate & severe cases of OSA after around 18 months of treatment with CPAP.76

As FES & ocular surface disease can impact patient’s vision and quality of life, the treatment specific to FES which targets the associated ocular surface disease should be advised and patient is advised to not sleep on their side or face. Lubricants and artificial tears are advised to ensure ocular surface health. Surgical intervention involves lid tightening surgery to shorten upper eyelid. So, it is very crucial for the physician to ask the patients with OSA about these symptoms at every routine visit.

Glaucoma

Glaucoma is described to be a chronic progressive optic neuropathy associated with visual field defects & cupping of the optic nerve. It is currently 2nd most common cause of blindness worldwide & has shown positive association with OSA.77, 78 Studies have shown association of OSA with both normal tension glaucoma (NTG) and open angle glaucoma (OAG).30, 69, 79 A meta-analysis study comprising 3 case control studies found OR of 2.46 for association between OSA & glaucoma, while same meta-analysis in cohort study demonstrated OR of 1.43.80 Various such case reports have shown such association. One of these reports showed that a 60-year-old patient of NTG who had progressive worsening of visual field in spite of controlled intra-ocular pressure with 2 anti-glaucoma drops and surgical intervention; after patient was diagnosed with OSA, and the treatment with nasal CPAP started, the patient visual field defects remained stabilised for 3.5 years of follow up.81

2 theories have been proposed for mechanism of glaucomatous changes of optic nerve in OSA i.e. mechanical and vascular theories. The mechanical theory says that the raised intraocular pressure [IOP] in OSA causes glaucomatous damage. Mechanical factors include being supine position, raised IOP related to obesity, raised nocturnal intracranial pressure, trabecular meshwork and lamina cribosa fibre depletion. Vascular theory includes predisposition of optic nerve to ischemia, repeated hypoxic episodes causing its damage, oxidative stress & inflammation.80, 81, 82 Due to the decreased perfusion and potential for ischaemic changes, optic nerve head in OSA becomes more sensitised to mechanical damage further80 However, there are many confounding factors in OSA and glaucoma, which are associated with poor perfusion to optic nerve head such as obesity, hypertension and diabetes.

Various studies have shown thinning of retinal nerve fibre layer [RNFL] which is a feature of early glaucomatous optic neuropathy, related with OSA.83, 84 Shiba et al. demonstrated that nasal RNFL & AHI have a negative co-relation.85 Visual loss and severity of OSA has also been shown to be co-related in various studies.83, 86, 87 Ulusoy et al in cross-sectional study showed that CPAP treated patients of OSA showed decreased IOP as compared to those who had untreated with OSA. Also untreated patients of OSA showed higher cup disc ratios.88

Non-Arteritic Anterior Ischemic Syndrome (NA-AION)

NA-AION is described as sudden loss of vision, usually unilateral, painless and occurs mostly upon waking.89 Eye examination reveals characteristic RAPD (if unilateral) and fundus abnormalities.90, 91 If bilateral NA-AION has developed, there will be absent RAPD, but both pupils show sluggish reactivity to light.

Stein et al. in his cohort study found 16% increased risk of developing NA-AION in patients who had untreated OSA as compared to those without OSA.92 Other studies have demonstrated the prevalence of OSA in patients with NA-AION to be 71-89%. A meta-analysis study reported that NA-AION patients are at five times more risk to OSA than the general population.89, 91, 93

Predisposing factors to NA-AION include obesity, hypertension, atherosclerosis and diabetes. It also involves anatomical risk factors e.g. small optic cup & small optic nerve head.94 So, patients taking multiple antihypertensive drugs are especially at risk for developing this ischemic disease. As the vision loss is irreversible, patient has only single normal eye i.e. contralateral eye. There is 15% risk of involvement of other eye over a period of 5 years. So, this demands urgent attention to alleviate the risk factors to avoid involvement of the contralateral eye in known cases of NA-AION with OSA.91

Pathogenesis of NA-AION is proposed to be vascular. It is thought to be developed due to ischemia of the short posterior ciliary artery supplying the optic nerve. Ischemia causes oedema at the site of nerve exit from eye causing further compression and hence vascular compromise.

Archer et al. found that the above mentioned 16% increased risk of developing NA-AION in patients with OSA was not present in those treated by CPAP, which further establish the relation between the two entities.89

Central serous chorio-retinopathy (CSCR)

It is the serous detachment of the neuro-sensory retina in the macular region typically seen in middle aged males. It presents as mild decrease in visual acuity, decreased contrast sensitivity, visual distortion and affects color vision.

Huon LK et al. in a meta-analysis found significant association between OSA & CSCR.79 Brodie et al. showed no significant association between the two.95

Both OSA & CSCR share common mechanism i.e. elevated serum cortisol levels and sympathetic tone causing vasospasm and endothelial cell dysregulation. This dysregulation in CSCR increases vascular permeability of choroidal vessels, hence fluid leaks from retinal capillaries causing oedema by building osmotic pressure gradient and pulling of fluid in choroid from RPE.96 CSCR is self resolving usually with most of the patients resuming their pre-disease visual acuity within 3 months.97

There are lacunae of study to ascertain the association of CSCR &OSA, so further studies are required.

Retinal vascular occlusion (RVO)

RVO is the 2nd most common cause of vascular blindness just next to diabetic retinopathy.79, 98 Vascular occlusion involves central retinal vein and branch of the retinal vein, latter being more common. Patients of RVO present with sudden painless, unilateral vision loss or new visual field defect.

Various studies have shown association between OSA & RVO. Glacet –bernard A et al. and Chou et al. found OSA to be associated with 77% cases of RVO based on nocturnal symptoms98 Mechanism of RVO with OSA is hypothesised to be hypercoagulability and retinal vessel inflammation due to raised nocturnal intracranial pressure.99 Also, hypoxia in the apnoeic event causes increased haematocrit values and hence is a predisposing factor in clot formation.100

A study demonstrated that regular use of CPAP in OSA patients caused decreased hypercoagulability and hence decreased risk to develop stroke and BRVO.

Papilledema

It is the swelling of the disc bilaterally involving raised ICP. Various studies have shown OSA and idiopathic intracranial hypertension [IIH] to be associated with each other.

Proposed mechanism is that during apnoeic episodes, the oxygen and carbon dioxide levels in blood decrease and increase respectively. It causes cerebral vasodilation and hence increase in blood volume intracranially. This in turn leads to venous stasis and raised ICP as seen in IIH.101

Marcus et al. showed that sleep disordered breathing was very common in cases with IIH but all the patients also had obesity.102 Another study found that with treatment of OSA, IIH improved symptomatically.103 Javaheri S et al also showed improvement of papillodema symptoms with OSA treatment. There are other studies available which dismiss their association.104 One such study was conducted by Thurtell MJ et al found no significant association of severity and prevalence of OSA as compared to the controls having similar body mass index and other demographic variables.105 Because of the variable results of different studies about association between the two entities, more studies are needed.

Keratoconus

It is the non- inflammatory ectatic condition of cornea which is characterized by progressive thinning and corneal steepening or protrusion.106 The prevalence of OSA in keratoconus patients was found to be 18%.107 Various studies have found that 18-20% of keratoconus patients having obesity are associated with OSA while in general population the prevalence of keratoconus being only 0.054%.108, 109 However, if obesity is removed as a risk factor, non- obese patients of keratoconus were not found to be associated with OSA.110 Contrary reports have been shown in another study which demonstrated no association between keratoconus & obesity and insignificant chances of occurrence of OSA in keratoconus patients.111

Management of Obstructive Sleep Apnea

Ocular complications may improve after appropriate management of OSA. McNab AA et al reported recurrence of surgically treated floppy eye syndrome in patients with untreated OSA.69 Management of OSA includes general measures like weight control, avoidance of alcohol, smoking and sedatives. The nasal continuous positive airway pressure (CPAP) is an effective measure to prevent the collapsibility of the upper airway.111 A comprehensive lifestyle intervention (CIL) program may significantly improve in obesity and OSA. CIL includes low calorie diet, increase physical activity/ exercise and behavioral modification.112

Conclusion

As it has already been discussed, hypoxia is the main culprit in the pathogenesis of OSA and it is a well established fact and proven by multiple studies that OSA increases risk of cardiovascular disorders like hypertension, atrial fibrillation, myocardial infarction, sudden death, arrhythmias, ischemic heart diseases. Above discussion indicates that OSA and ophthalmic involvement have close association. Also, several ophthalmic diseases have also shown improvement with the treatment of OSA i.e, CPAP. Almost all the ophthalmic entities described above are chronic in their course and may involve visual worsening or even blinding outcomes like visual field defects in glaucoma, vascular occlusions and NA-AION. So, it becomes even more necessary to diagnose these diseases at right time and proper follow up at regular intervals. It is highly essential that physicians treating OSA patients should consider ophthalmology consultation at time of diagnosis only as OSA itself is underdiagnosed disease. And by the time it is diagnosed it might have affected the eye as well.

Source of Funding

None.

Conflict of Interest

The authors declare that there is no conflict of interest.

References

1 

H Gastaut CA Tassinari B Duron Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the pickwick syndromeBrain Res1966121678610.1016/0006-8993(66)90117-x

2 

NM Punjabi The Epidemiology of Adult Obstructive Sleep ApneaProc Am Thorac Soc2008521364310.1513/pats.200709-155mg

3 

PE Peppard T Young JH Barnet M Palta EW Hagen KM Hla Increased Prevalence of Sleep-Disordered Breathing in AdultsAm J Epidemiol2013177910061410.1093/aje/kws342

4 

T Young M Palta J Dempsey J Skatrud S Weber S Badr The Occurrence of Sleep-Disordered Breathing among Middle-Aged AdultsN Engl J Med1993328171230510.1056/nejm199304293281704

5 

S Wang S Li B Wang Matrix metalloproteinase-9 is a predictive factor for systematic hypertension and heart dysfunction in patients with obstructive sleep apnea syndromeBiomed Res Int20182018156970110.1155/2018/1569701

6 

AM Osman SG Carter JC Carberry DJ Eckert Obstructive sleep apnea: current perspectivesNat Sci Sleep201810213410.2147/nss.s124657

7 

LV Pham AR Schwartz The pathogenesis of obstructive sleep apneaJ Thorac Dis201578135872

8 

SD West C Turnbull Obstructive sleep apnoeaEyeVol. 32Springer Science and Business Media LLCLondon, UK201888990310.1038/s41433-017-0006-y

9 

RM Barewal Obstructive sleep apnea: the role of gender in prevalence, symptoms, and treatment successDent Clin North Am2019632297308

10 

KA Franklin E Lindberg Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apneaJ Thorac Dis20157131122

11 

G Jean-Louis F Zizi LT Clark CD Brown SI McFarlane Obstructive Sleep Apnea and Cardiovascular Disease: Role of the Metabolic Syndrome and Its ComponentsJ Clin Sleep Med200804032617210.5664/jcsm.27191

12 

W Xie F Zheng X Song Obstructive Sleep Apnea and Serious Adverse Outcomes in Patients with Cardiovascular or Cerebrovascular DiseaseMedicine201493e33610.1097/md.0000000000000336

13 

M Santos RJ Hofmann Ocular Manifestations of Obstructive Sleep ApneaJ Clin Sleep Med201713111345810.5664/jcsm.6812

14 

P Hirunwiwatkul V Puangsricharern N Sothornwit PR Pongpun J Sawatdiwithayayong P Hirunwiwatkul Eye diseases associated with obstructive sleep apnea syndrome in an Asian populationAsian Biome2010446455010.2478/abm-2010-0083

15 

DS Mojon CW Hess D Goldblum J Fleischhauer F Koerner C Bassetti High prevalence of glaucoma in patients with sleep apnea syndromeOphthalmology1999106510091210.1016/s0161-6420(99)00525-4

16 

NA Antic P Catcheside C Buchan M Hensley MT Naughton S Rowland The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSASleep2011341111910.1093/sleep/34.1.111

17 

E Romero B Krakow P Haynes V Ulibarri Nocturia and snoring: predictive symptoms for obstructive sleep apneaSleep Breath20101443374310.1007/s11325-009-0310-2

18 

AT Mulgrew CF Ryan JA Fleetham R Cheema N Fox M Koehoorn The impact of obstructive sleep apnea and daytime sleepiness on work limitationSleep Med200791425310.1016/j.sleep.2007.01.009

19 

ME Howard AV Desai RR Grunstein C Hukins JG Armstrong D Joffe Sleepiness, Sleep-disordered Breathing, and Accident Risk Factors in Commercial Vehicle DriversAm J Respir Crit Care Med2004170910142110.1164/rccm.200312-1782oc

20 

R A Stoohs C Guilleminault A Itoi W C Dement Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesitySleep1994177619623

21 

DJ Eckert Phenotypic approaches to obstructive sleep apnoea – New pathways for targeted therapySleep Med Rev201837455910.1016/j.smrv.2016.12.003

22 

DJ Eckert DP White AS Jordan A Malhotra A Wellman Defining Phenotypic Causes of Obstructive Sleep Apnea. Identification of Novel Therapeutic TargetsAm J Respir Crit Care Med20131888996100410.1164/rccm.201303-0448oc

23 

E Ito S Tsuiki K Maeda I Okajima Y Inoue Oropharyngeal Crowding Closely Relates to Aggravation of OSAChest201615023465210.1016/j.chest.2016.03.005

24 

RJ Schwab M Pasirstein R Pierson A Mackley R Hachadoorian R Arens Identification of Upper Airway Anatomic Risk Factors for Obstructive Sleep Apnea with Volumetric Magnetic Resonance ImagingAm J Respir Crit Care Med200316855223010.1164/rccm.200208-866oc

25 

Y Segal A Malhotra G Pillar Upper airway length may be associated with the severity of obstructive sleep apnea syndromeSleep Breath2008124311610.1007/s11325-008-0191-9

26 

DL Morrison SH Launois S Isono TR Feroah WA Whitelaw JE Remmers Pharyngeal Narrowing and Closing Pressures in Patients with Obstructive Sleep ApneaAm Rev Respir Dis199314836061110.1164/ajrccm/148.3.606

27 

O Resta MP Foschino-Barbaro G Legari S Talamo P Bonfitto A Palumbo Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjectsInt J Obes20012556697510.1038/sj.ijo.0801603

28 

LF Drager HF Lopes C Maki-Nunes IC Trombetta E Toschi-Dias MJNN Alves The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic SyndromePLoS ONE201058e1206510.1371/journal.pone.0012065

29 

LF Drager SM Togeiro VY Polotsky Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndromeJ Am Coll Cardiol20136256976

30 

Y Shinmei T Nitta H Saito T Ohguchi R Kijima S Chin Continuous Intraocular Pressure Monitoring During Nocturnal Sleep in Patients With Obstructive Sleep Apnea SyndromeInvestig Opthalmol Vis Sci2016576282410.1167/iovs.16-19220

31 

JM Marin SJ Carrizo E Vicente AGN Agusti Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyLancet2005365946410465310.1016/s0140-6736(05)71141-7

32 

J Alvarez-Sabín O Romero P Delgado M Quintana E Santamarina A Ferré Obstructive sleep apnea and silent cerebral infarction in hypertensive individualsJ Sleep Res2018272232910.1111/jsr.12571

33 

F Porto YS Sakamoto C Salles Association between Obstructive Sleep Apnea and Myocardial Infarction: A Systematic ReviewArq Bras Cardiol2017108361910.5935/abc.20170031

34 

AN Vgontzas EO Bixler GP Chrousos Sleep apnea is a manifestation of the metabolic syndromeSleep Med Rev2005932112410.1016/j.smrv.2005.01.006

35 

SR Coughlin L Mawdsley JA Mugarza PM Calverley JP Wilding Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndromeEur Heart J20042573541

36 

A Gruber F Horwood J Sithole NJ Ali I Idris Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance stateCardiovasc2006522

37 

N McArdle D Hillman L Beilin G Watts Metabolic Risk Factors for Vascular Disease in Obstructive Sleep ApneaAm J Respir Crit Care Medi20071752190510.1164/rccm.200602-270oc

38 

M Kono K Tatsumi T Saibara A Nakamura N Tanabe Y Takiguchi Obstructive Sleep Apnea Syndrome Is Associated With Some Components of Metabolic SyndromeChest2007131513879210.1378/chest.06-1807

39 

M Tijhonen M Partinen S Na¨rva¨nen The severity of obstructive sleep apnoea is associated with insulin resistanceJ Sleep Res199325661

40 

KP Strohl RD Novak W Singer C Cahan KD Boehm CW Denko Insulin Levels, Blood Pressure and Sleep ApneaSleep1994177614810.1093/sleep/17.7.614

41 

AN Vgontzas DA Papanicolaou EO Bixler K Hopper A Lotsikas HM Lin Sleep Apnea and Daytime Sleepiness and Fatigue: Relation to Visceral Obesity, Insulin Resistance, and HypercytokinemiaJ Clin Endocrinol Metab20008531151810.1210/jcem.85.3.6484

42 

N Meslier F Gagnadoux P Giraud C Person H Ouksel T Urban Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndromeEur Respir J20032211566010.1183/09031936.03.00089902

43 

F Tassone F Lanfranco L Gianotti S Pivetti F Navone R Rossetto Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variablesClin Endocrinol2003593374910.1046/j.1365-2265.2003.01859.x

44 

AC Peltier FB Consens K Sheikh L Wang Y Song JW Russell Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulationSleep Med2007821495510.1016/j.sleep.2006.06.010

45 

S Makino H Handa K Suzukawa M Fujiwara M Nakamura S Muraoka Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistanceClin Endocrinol200664112910.1111/j.1365-2265.2005.02407.x

46 

N Peled M Kassirer D Shitrit Y Kogan D Shlomi AS Berliner The association of OSA with insulin resistance, inflammation and metabolic syndromeRespir Med200710181696170110.1016/j.rmed.2007.02.025

47 

A Elmasry E Lindberg C Berne C Janson T Gislason MA Tageldin Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based studyJ Intern Med200124921536110.1046/j.1365-2796.2001.00787.x

48 

NHM Punjabi JD Sorkin LI Katzel AP Goldberg AR Schwartz PL Smith Sleep-disordered Breathing and Insulin Resistance in Middle-aged and Overweight MenAm J Respir Crit Care Med200216556778210.1164/ajrccm.165.5.2104087

49 

MSM Ip B Lam MMT Ng WK Lam KWT Tsang KSL Lam Obstructive Sleep Apnea Is Independently Associated with Insulin ResistanceAm J Respir Crit Care Med20021655670610.1164/ajrccm.165.5.2103001

50 

NM Punjabi Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health StudyAm J Epidemiol200416065213010.1093/aje/kwh261

51 

M Okada A Takamizawa K Tsushima K Urushihata K Fujimoto K Kubo Relationship between Sleep-Disordered Breathing and Lifestyle-related Illnesses in Subjects Who Have Undergone Health-screeningIntern Med20064515891610.2169/internalmedicine.45.1592

52 

L Sulit A Storfer-Isser H Lester Kirchner S Redline Differences in Polysomnography Predictors for Hypertension and Impaired Glucose ToleranceSleep20062967778310.1093/sleep/29.6.777

53 

T Young L Finn PE Peppard M Szklo-Coxe D Austin FJ Nieto Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohortSleep200831810718

54 

R Schulz S Mahmoudi K Hattar U Sibelius H Olschewski K Mayer Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapyAm J Respir Crit Care Med200016225667010.1164/ajrccm.162.2.9908091

55 

L Lavie Obstructive sleep apnoea syndrome – an oxidative stress disorderSleep Med Rev200371355110.1053/smrv.2002.0261

56 

YJ Suzuki V Jain AM Park RM Day Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseasesFree Radical Biol Med2006401016839210.1016/j.freeradbiomed.2006.01.008

57 

GE Foster MJ Poulin PJ Hanly Intermittent hypoxia and vascular function: implications for obstructive sleep apnoeaExp Physiol2007921516510.1113/expphysiol.2006.035204

58 

M Yamauchi H Nakano J Maekawa Y Okamoto Y Ohnishi T Suzuki Oxidative Stress in Obstructive Sleep ApneaChest2005127516741910.1378/chest.127.5.1674

59 

K Spiegel E Tasali P Penev EV Cauter Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and AppetiteAnn Intern Med2004141118465010.7326/0003-4819-141-11-200412070-00008

60 

KL Knutson K Spiegel P Penev EV Cauter The metabolic consequences of sleep deprivationSleep Med Rev20071131637810.1016/j.smrv.2007.01.002

61 

E Cauter U Holmbäck K Knutson R Leproult A Miller A Nedeltcheva Impact of Sleep and Sleep Loss on Neuroendocrine and Metabolic FunctionHorm Res Paediatr20076712910.1159/000097543

62 

VK Somers DP White R Amin Sleep apnea and cardiovascular disease: an American heart association/American college of cardiology foundation scientific statement from the American heart association council for high blood pressure research professional education committee council on clinical cardiology, stroke council, and council on cardiovascular nursing. In collaboration with the national heart, lung, and blood institute national center on sleep disorders research (national institutes of health)J Am Coll Cardiol200811810801111

63 

K Li Z Chen Y Qin Plasma YKL-40 levels are associated with hypertension in patients with obstructive sleep apneaBiomed Res Int201920195193597

64 

M Harris N Glozier R Ratnavadivel RR Grunstein Obstructive sleep apnea and depressionSleep Med Rev20091364374410.1016/j.smrv.2009.04.001

65 

Y Yamashiro MH Kryger Why Should Sleep Apnea Be Diagnosed and Treated?Clin Pulm Med199414250910.1097/00045413-199407000-00007

66 

O Parra A Arboix JM Montserrat L Quintó S Bechich L García-Eroles Sleep-related breathing disorders: impact on mortality of cerebrovascular diseaseEur Respir J20042422677210.1183/09031936.04.00061503

67 

MR Bonsignore O Marrone G Insalaco G. Bonsignore The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanismsEur Respir J19947478680510.1183/09031936.94.07040786

68 

EC Fletcher The relationship between systemic hypertension and obstructive sleep apnea: facts and theoryAm J Med19959811828

69 

AA McNab The eye and sleep apneaSleep Med Rev20071142697610.1016/j.smrv.2007.03.006

70 

J Chambe S Laib J Hubbard C Erhardt E Ruppert C Schroder Floppy eyelid syndrome is associated with obstructive sleep apnoea: a prospective study on 127 patientsJ Sleep Res20122133081510.1111/j.1365-2869.2011.00968.x

71 

DG Ezra M Beaconsfield R Collin Floppy Eyelid Syndrome: Stretching the LimitsSurv Ophthalmol2010551354610.1016/j.survophthal.2009.02.025

72 

I Leibovitch D Selva Floppy eyelid syndrome: Clinical features and the association with obstructive sleep apneaSleep Med2006721172210.1016/j.sleep.2005.07.001

73 

EE Moscato A Jian-Amado Floppy eyelid syndromeCompr Ophthalml Update2007825965

74 

C Miyamoto LCE Santo L Roisman PAM Moreno AJ Cariello MH Osaki Floppy eyelid syndrome: reviewArq Bras Cardiol201174164610.1590/s0004-27492011000100016

75 

M Acar H Firat U Acar S Ardic Ocular surface assessment in patients with obstructive sleep apnea–hypopnea syndromeSleep Breath2013172583810.1007/s11325-012-0724-0

76 

M Acar H Fırat M Yuceege S Ardıc Long-term effects of PAP on ocular surface in obstructive sleep apnea syndromeCan J Ophthalmol20144922172110.1016/j.jcjo.2013.11.010

77 

CC Lin CC Hu JD Ho HW Chiu HC Lin Obstructive sleep apnea and increased risk of glaucoma: a population based matched cohort studyOphthalmology20131208155964

78 

EB Ohana MB Blumen E Bluwol M Derri F Chabolle JP Nordmann Primary open angle glaucoma and snoring: Prevalence of OSASEur Ann Otorhinolaryngol Head Neck Dis201012751596410.1016/j.anorl.2010.07.003

79 

LK Huon S Yung-Chuan Liu M Camacho C Guilleminault The association between ophthalmologic diseases and obstructive sleep apnea: a systematic review and meta-analysisSleep Breath201620411455410.1007/s11325-016-1358-4

80 

Y Shi P Liu J Guan Y Lu K Su Association between Glaucoma and Obstructive Sleep Apnea Syndrome: A Meta-Analysis and Systematic ReviewPLOS ONE2015102e011562510.1371/journal.pone.0115625

81 

S Kremmer JM Selbach HD Ayertey KP Steuhl Normal tension glaucoma, sleep apnea syndrome and nasal continuous positive airway pressure therapy--case report with a review of literatureKlin Monbl Augenheilkd200121842638

82 

B Ferrandez A Ferreras P Calvo B Abadia JM Marin AB Pajarin Assessment of the retinal nerve fiber layer in individuals with obstructive sleep apneaBMC Ophthalmol20161614010.1186/s12886-016-0216-2

83 

M Sergi DE Salerno M Rizzi M Blini A Andreoli D Messenio Prevalence of Normal Tension Glaucoma in Obstructive Sleep Apnea Syndrome PatientsJ Glaucoma200716142610.1097/01.ijg.0000243472.51461.24

84 

S H Kargi R Altin M Koksal L Kart F Cinar SH Ugurbas Retinal nerve fibre layer measurements are reduced in patients with obstructive sleep apnoea syndromeEye2005195575910.1038/sj.eye.6701582

85 

T Shiba M Takahashi Y Sato Y Onoda Y Hori T Sugiyama Relationship between Severity of Obstructive Sleep Apnea Syndrome and Retinal Nerve Fiber Layer ThicknessAm J Ophthalmol201415761202810.1016/j.ajo.2014.01.028

86 

S Karakucuk S Goktas M Aksu N Erdogan S Demirci A Oner Ocular blood flow in patients with obstructive sleep apnea syndrome (OSAS)Graefes Arch Clin Exp Ophthalmol200724611293410.1007/s00417-007-0656-8

87 

CSL Tsang SL Chong CK Ho MF Li Moderate to severe obstructive sleep apnoea patients is associated with a higher incidence of visual field defectEye2006201384210.1038/sj.eye.6701785

88 

S Ulusoy M Erden M Emre Dinc N Yavuz E Caglar A Dalgic Effects of Use of a Continuous Positive Airway Pressure Device on GlaucomaMed Sci Monit2015213415910.12659/msm.895897

89 

EL Archer S Pepin Obstructive Sleep Apnea and Nonarteritic Anterior Ischemic Optic Neuropathy: Evidence for an AssociationJ Clin Sleep Med20130906613810.5664/jcsm.2766

90 

H Abdul J Pizzimenti C Purvis The eye in sleep apnea syndromeSleep Med2006721071510.1016/j.sleep.2005.08.010

91 

ED Gaier N Torun The enigma of nonarteritic anterior ischemic optic neuropathyCurr Opin Ophthalmol201627649850410.1097/icu.0000000000000318

92 

JD Stein DS Kim KM Mundy N Talwar B Nan RD Chervin The Association between Glaucomatous and Other Causes of Optic Neuropathy and Sleep ApneaAm J Ophthalmol2011152698998.e310.1016/j.ajo.2011.04.030

93 

F Aptel H Khayi JL Pépin R Tamisier P Levy JP Romanet Association of Nonarteritic Ischemic Optic Neuropathy With Obstructive Sleep Apnea SyndromeJAMA Ophthalmol2015133779710.1001/jamaophthalmol.2015.0893

94 

V Biousse NJ Newman Ischemic Optic NeuropathiesN Engl J Med20153722524283610.1056/nejmra1413352

95 

FL Brodie ES Charlson TS Aleman RT Salvo DY Gewaily MK Lau Obstructive sleep apnea and central serous chorioretinopathyRetina20153522384310.1097/iae.0000000000000326

96 

B Nicholson J Noble F Forooghian C Meyerle Central Serous Chorioretinopathy: Update on Pathophysiology and TreatmentSurv Ophthalmol20135821032610.1016/j.survophthal.2012.07.004

97 

R Liegl MW Ulbig Central Serous ChorioretinopathyOphthalmologica20142322657610.1159/000360014

98 

A Glacet-Bernard G Leroux Les Jardins S Lasry G Coscas G Soubrane E Souied Obstructive sleep apnea among patients with retinal vein occlusionArch Ophthalmol20101281215338

99 

DP Grover Obstructive sleep apnea and ocular disordersCurr Opin Ophthalmol2010216454810.1097/icu.0b013e32833f00dc

100 

C Liak M Fitzpatrick Coagulability in Obstructive Sleep ApneaCan Respir J20111863384810.1155/2011/924629

101 

P Jennum SE Børgesen Intracranial Pressure and Obstructive Sleep ApneaChest19899522798310.1378/chest.95.2.279

102 

DM Marcus J Lynn JJ Miller O Chaudhary D Thomas B Chaudhary Sleep Disorders: A Risk Factor for Pseudotumor Cerebri?J Neuro-Ophthalmol2001212121310.1097/00041327-200106000-00014

103 

AG Lee K Golnik R Kardon M Wall E Eggenberger S Yedavally Sleep apnea and intracranial hypertension in menOphthalmology20021093482510.1016/s0161-6420(01)00987-3

104 

S Javaheri Z Qureshi K Golnik Resolution of Papilledema Associated with OSA TreatmentJ Clin Sleep Med2011070439940010.5664/jcsm.1202

105 

MJ Thurtell LM Trotti EO Bixler DB Rye DL Bliwise NJ Newman Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population dataJ Neurol2013260717485110.1007/s00415-013-6858-6

106 

V Arora R Shetty L Kaweri N Pahuja H Nagaraja K Wadia Current review and a simplified "five-point management algorithm" for keratoconusIndian J Ophthalmol2015631465310.4103/0301-4738.151468

107 

PK Gupta SS Stinnett AN Carlson Prevalence of Sleep Apnea in Patients With KeratoconusCornea2012316595910.1097/ico.0b013e31823f8acd

108 

MA Saidel JY Paik C Garcia P Russo D Cao C Bouchard Prevalence of Sleep Apnea Syndrome and High-Risk Characteristics Among Keratoconus PatientsCornea2012316600310.1097/ico.0b013e318243e446

109 

RH Kennedy WM Bourne JA Dyer A 48-Year Clinical and Epidemiologic Study of KeratoconusAm J Ophthalmol198610132677310.1016/0002-9394(86)90817-2

110 

B Gencer EB Ozgurhan S Kara HA Tufan S Arikan E Bozkurt Obesity and Obstructive Sleep Apnea in Patients With Keratoconus in a Turkish PopulationCornea20143321374010.1097/ico.0000000000000024

111 

CE Sullivan FG Issa M Berthon- Jones Reversal of obstructive apnea by continuous positive airway pressure applied through the naresLancet198118225862510.1016/s0140-6736(81)92140-1.

112 

HP Tuomilehto JM Seppa MM Partinen M Peltonen H Gylling JO Tuomilehto Lifestyle intervention with weight reduction: first line treatment in mild obstructive sleep apneaAm J Respir Crit Care Med20091793207



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

275-283


Authors Details

Rajendra P Maurya*, Manisha, Vibha Singh, Ashish Gupta, Sushil Kumar Agarwal, Virendra P Singh, Mahendra K Singh, G N Srivastav, Syeed Mehbub Ul Kadir


Article History

Received : 28-05-2021

Accepted : 05-06-2021


Article Metrics


View Article As

 


Downlaod Files